California State Teachers Retirement System lowered its holdings in Healthequity Inc (NASDAQ:HQY) by 9.7% in the 3rd quarter, HoldingsChannel reports. The fund owned 79,794 shares of the company’s stock after selling 8,530 shares during the quarter. California State Teachers Retirement System’s holdings in Healthequity were worth $4,036,000 at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in the company. Albion Financial Group UT grew its holdings in Healthequity by 1.4% during the 2nd quarter. Albion Financial Group UT now owns 8,694 shares of the company’s stock valued at $433,000 after purchasing an additional 120 shares in the last quarter. Oppenheimer Asset Management Inc. grew its holdings in Healthequity by 7.7% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 2,686 shares of the company’s stock valued at $134,000 after purchasing an additional 191 shares in the last quarter. Suntrust Banks Inc. grew its holdings in Healthequity by 2.7% during the 2nd quarter. Suntrust Banks Inc. now owns 9,408 shares of the company’s stock valued at $468,000 after purchasing an additional 250 shares in the last quarter. NBW Capital LLC grew its holdings in Healthequity by 0.8% during the 2nd quarter. NBW Capital LLC now owns 37,266 shares of the company’s stock valued at $1,857,000 after purchasing an additional 292 shares in the last quarter. Finally, D.A. Davidson & CO. grew its holdings in Healthequity by 15.2% during the 2nd quarter. D.A. Davidson & CO. now owns 3,326 shares of the company’s stock valued at $165,000 after purchasing an additional 439 shares in the last quarter. 98.27% of the stock is owned by institutional investors.
Healthequity Inc (NASDAQ:HQY) opened at $48.44 on Friday. Healthequity Inc has a 52 week low of $37.62 and a 52 week high of $55.31. The company has a market cap of $2,913.50, a price-to-earnings ratio of 65.46, a price-to-earnings-growth ratio of 1.98 and a beta of 1.74.
Healthequity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, December 5th. The company reported $0.17 EPS for the quarter, beating the Zacks’ consensus estimate of $0.13 by $0.04. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The firm had revenue of $56.80 million for the quarter, compared to the consensus estimate of $55.27 million. During the same period in the prior year, the firm posted $0.10 EPS. The firm’s revenue was up 31.0% compared to the same quarter last year. sell-side analysts expect that Healthequity Inc will post 0.71 EPS for the current year.
In other Healthequity news, VP Darcy G. Mott sold 9,500 shares of the stock in a transaction on Friday, October 20th. The shares were sold at an average price of $49.90, for a total transaction of $474,050.00. Following the transaction, the vice president now directly owns 90,500 shares in the company, valued at approximately $4,515,950. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Berkley Capital, Llc sold 373,500 shares of the stock in a transaction on Monday, November 6th. The shares were sold at an average price of $53.21, for a total transaction of $19,873,935.00. The disclosure for this sale can be found here. Insiders have sold a total of 1,445,573 shares of company stock worth $75,519,359 over the last quarter. 29.00% of the stock is currently owned by insiders.
A number of equities research analysts recently weighed in on the stock. BidaskClub raised shares of Healthequity from a “sell” rating to a “hold” rating in a report on Thursday, September 28th. Zacks Investment Research raised shares of Healthequity from a “hold” rating to a “buy” rating and set a $58.00 price target for the company in a report on Wednesday, October 11th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $56.00 price target on shares of Healthequity in a report on Monday, September 25th. Robert W. Baird reaffirmed a “hold” rating on shares of Healthequity in a report on Thursday, September 21st. Finally, Citigroup assumed coverage on shares of Healthequity in a report on Thursday. They set a “buy” rating for the company. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Healthequity currently has an average rating of “Buy” and a consensus price target of $58.33.
ILLEGAL ACTIVITY WARNING: This news story was originally reported by Equities Focus and is the sole property of of Equities Focus. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.equitiesfocus.com/2018/01/07/california-state-teachers-retirement-system-sells-8530-shares-of-healthequity-inc-hqy.html.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.